Production planning for medical devices with an uncertain regulatory approval date

被引:7
|
作者
Hill, AV [1 ]
Sawaya, WJ [1 ]
机构
[1] Univ Minnesota, Curtis L Carlson Sch Management, Operat & Management Sci Dept, Minneapolis, MN 55455 USA
关键词
D O I
10.1080/07408170490247458
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The demand for medical devices such as pacemakers, defibrillators, catheters and heart valves is growing rapidly throughout the world. This demand is driven by both the "technology push" of new medical device technologies and the "demand pull" of an aging population in North America, Western Europe, and Japan. Production planning for these products is increasing in importance as demand increases, global competition intensifies and product lifecycles shorten. In all developed countries, medical devices must pass through a government approval process. An uncertain government approval date makes it difficult to create production and inventory plans for both the phase-out of an existing product and the phase-in of a replacement product. This paper presents a mathematical model for finding the optimal dates to stop production of an existing product and to start production of a new product in the presence of an uncertain approval date. The paper also presents an example and reports on an implementation in a Fortune 500 medical device firm.
引用
收藏
页码:307 / 317
页数:11
相关论文
共 50 条
  • [1] Regulatory approval of new medical devices: cross sectional study
    Marcus, Hani J.
    Payne, Christopher J.
    Hughes-Hallett, Archie
    Marcus, Adam P.
    Yang, Guang-Zhong
    Darzi, Ara
    Nandi, Dipankar
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [2] Patient-reported outcomes in the regulatory approval of medical devices
    Samantha Cruz Rivera
    Andrew P. Dickens
    Olalekan Lee Aiyegbusi
    Rebecca Flint
    Camilla Fleetcroft
    Duncan McPherson
    Philip Collis
    Melanie J. Calvert
    [J]. Nature Medicine, 2021, 27 : 2067 - 2068
  • [3] Patient-reported outcomes in the regulatory approval of medical devices
    Cruz Rivera, Samantha
    Dickens, Andrew P.
    Aiyegbusi, Olalekan Lee
    Flint, Rebecca
    Fleetcroft, Camilla
    McPherson, Duncan
    Collis, Philip
    Calvert, Melanie J.
    [J]. NATURE MEDICINE, 2021, 27 (12) : 2067 - 2068
  • [4] Planning pharmaceutical manufacturing networks in the light of uncertain production approval times
    Blossey, Gregor
    Hahn, Gerd J.
    Koberstein, Achim
    [J]. INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS, 2022, 244
  • [5] Regulatory responses and approval status of artificial intelligence medical devices with a focus on China
    Liu, Yuehua
    Yu, Wenjin
    Dillon, Tharam
    [J]. NPJ DIGITAL MEDICINE, 2024, 7 (01):
  • [6] Assessment of the Regulatory Approval Process of Medical Devices in Ethiopia: A Mixed Sequential Explanatory Study
    Fufa, Kebede
    Marew, Tesfa
    Ashenef, Ayenew
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (05) : 987 - 996
  • [7] Assessment of the Regulatory Approval Process of Medical Devices in Ethiopia: A Mixed Sequential Explanatory Study
    Kebede Fufa
    Tesfa Marew
    Ayenew Ashenef
    [J]. Therapeutic Innovation & Regulatory Science, 2023, 57 : 987 - 996
  • [8] United States regulatory approval of medical devices and software applications enhanced by artificial intelligence
    Yaeger, Kurt A.
    Martini, Michael
    Yaniv, Gal
    Oermann, Eric K.
    Costa, Anthony B.
    [J]. HEALTH POLICY AND TECHNOLOGY, 2019, 8 (02) : 192 - 197
  • [9] Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment
    Timbie, Justin W.
    Kim, Alice Y.
    Concannon, Thomas W.
    [J]. VALUE IN HEALTH, 2021, 24 (12) : 1792 - 1798
  • [10] PRE-APPROVAL PROMOTION OF MEDICAL DEVICES
    PETTY, MD
    [J]. FOOD AND DRUG LAW JOURNAL, 1994, 49 (04): : 541 - 551